The DOI matches its Crossref record; 645 of the 645 references it cites were found in a registry or an index.
2022 Alzheimer's disease facts and figures
Abstract
This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality and morbidity, use and costs of care, and the overall impact on family caregivers, the dementia workforce and society. The Special Report discusses consumers' and primary care physicians' perspectives on awareness, diagnosis and treatment of mild cognitive impairment (MCI), including MCI due to Alzheimer's disease. An estimated 6.5 million Americans age 65 and older are living with Alzheimer's dementia today. This number could grow to 13.8 million by 2060 barring the development of medical breakthroughs to prevent, slow or cure AD. Official death certificates recorded 121,499 deaths from AD in 2019, the latest year for which data are available. Alzheimer's disease was officially listed as the sixth‐leading cause of death in the United States in 2019 and the seventh‐leading cause of death in 2020 and 2021, when COVID‐19 entered the ranks of the top ten causes of death. Alzheimer's remains the fifth‐leading cause of death among Americans age 65 and older. Between 2000 and 2019, deaths from stroke, heart disease and HIV decreased, whereas reported deaths from AD increased more than 145%. More than 11 million family members and other unpaid caregivers provided an estimated 16 billion hours of care to people with Alzheimer's or other dementias in 2021. These figures reflect a decline in the number of caregivers compared with a decade earlier, as well as an increase in the amount of care provided by each remaining caregiver. Unpaid dementia caregiving was valued at $271.6 billion in 2021. Its costs, however, extend to family caregivers’ increased risk for emotional distress and negative mental and physical health outcomes — costs that have been aggravated by COVID‐19. Members of the dementia care workforce have also been affected by COVID‐19. As essential care workers, some have opted to change jobs to protect their own health and the health of their families. However, this occurs at a time when more members of the dementia care workforce are needed. Average per‐person Medicare payments for services to beneficiaries age 65 and older with AD or other dementias are almost three times as great as payments for beneficiaries without these conditions, and Medicaid payments are more than 22 times as great. Total payments in 2022 for health care, long‐term care and hospice services for people age 65 and older with dementia are estimated to be $321 billion. A recent survey commissioned by the Alzheimer's Association revealed several barriers to consumers’ understanding of MCI. The survey showed low awareness of MCI among Americans, a reluctance among Americans to see their doctor after noticing MCI symptoms, and persistent challenges for primary care physicians in diagnosing MCI. Survey results indicate the need to improve MCI awareness and diagnosis, especially in underserved communities, and to encourage greater participation in MCI‐related clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedLeng, M., Zhao, Y., Xiao, H., Li, C., & Wang, Z. (2020) · Journal of Medical Internet Research · doi:10.2196/19468 · Cited by 183
RetractedMcKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Centers for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Structural racism and health inequities in the USA: evidence and interventions
Bailey, Z. D., Krieger, N., Agénor, M., Graves, J., Linos, N., & Bassett, M. T. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30569-x · Cited by 5,203
Research works printed but not linked: 23
- Grossberg GT, 2010, The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: Recommendations of an expert consensus panel, Prim Care Companion J Clin Psychiatry, 12
- Institute of Medicine, 2015, Cognitive Aging: Progress in Understanding and Opportunity for Action
- 10.1097/EDE.0000000000000513 · DOI · Paper page
- 10.1001/jamanetworkopen.2021.1001 · DOI · Paper page
- Manly JJ, 2004, Critical perspectives on racial and ethnic differentials in health in late life, 95
- 10.1093/gerona/gly236 · DOI
- 10.1001/jama.2018.0158 · DOI
- 10.1177/1533317517749465 · DOI
- 10.1093/geront/gnaa108 · DOI · Paper page
- Maslow K, 2012, Translating Innovation to Impact: Evidence‐Based Interventions to Support People with Alzheimer's Disease and their Caregiver at Home and in the Community
- Whitlatch CJ, 2018, Meeting the informational, educational, and psychosocial support needs of persons living with dementia and their family caregivers, Gerontologist, 58, S58
- Rao A, 2017, Dementia neurology deserts: What are they and where are they located in the US?, Alzheimers Dement, 13, P509
- Khatutsky G, 2011, Understanding direct care workers: A snapshot of two of America's most important jobs: Certified nursing assistants and home health aides
- Stone R, 2012, Universal Coverage of Long‐Term Care in the United States: Can We Get There from Here?, 155
- Jones AL, 2009, The National Nursing Home Survey: 2004 Overview, Vital Health Stat 13, 1
- 10.1002/(SICI)1099-1166(199903)14:3<197::AID-GPS972>3.0.CO;2-Q · doi:10.1002/(sici)1099-1166(199903)14:3<197::aid-gps972>3.0.co;2-q
- The Gerontological Society of America. The GSA KAER Toolkit for Primary Care Teams: Supporting Conversations about Brain Health Timely Detection of Cognitive Impairment and Accurate Diagnosis of Dementia. Fall 2020 Edition. Available at:https://www.geron.org/images/gsa/Marketing/KAER/GSA_KAER‐Toolkit_2020_Final.pdf. Accessed October 22 2021.
- 10.1097/WCO.0000000000000779 · DOI
- Harris‐Kojetin L, 2019, Long‐term care providers and services users in the United States, 2015‐2016. National Center for Health Statistics, Vital Health Stat, 3
- CaffreyC SenguptaM MelekinA. Residential care community resident characteristics: United States 2018. NCHS Data Brief No. 404 September 2021. · doi:10.15620/cdc:103826
- U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services, 2021, 42 CFR Part 418 [CMS‐1754‐F] RIN 0938‐AU41. Medicare Program; FY 2022 Hospice Wage Index and Payment Rate, Hospice Conditions of ParticipationUpdates, Hospice and Home Health Quality Reporting Program Requirements Update, Federal Register, 86, 42528
- 10.1002/alz.057470 · doi:10.1002/alz.057470
- Rhoads K, 2021, UW Project ECHO‐Dementia: Implementation of a virtual clinic and telementoring program to improve dementia diagnosis and treatment in rural and under‐resourced primary care settings, Alzheimers Dement, 17, e051217, 10.1002/alz.051217 · doi:10.1002/alz.051217
Cited by
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019
Li, X., Feng, X., Sun, X., Hou, N., Han, F., & Liu, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.937486 · Cited by 703
Skrzypczak-Wiercioch, A., & Sałat, K. (2022) · Molecules · doi:10.3390/molecules27175481 · Cited by 406
Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives
Zhang, Z., Yang, X., Song, Y.-Q., & Tu, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101464 · Cited by 369
Tau-targeting therapies for Alzheimer disease: Current status and future directions
Congdon, E. E., Ji, C., Tetlow, A. M., Jiang, Y., & Sigurdsson, E. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00883-2 · Cited by 371
“In addition to the direct impact on patients, AD and related illnesses cost hundreds of billions of dollars to care-givers and the health-care system 2 .”
BackgroundInfluentialWięckowska-Gacek, A., Mietelska-Porowska, A., Wydrych, M., & Wojda, U. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101397 · Cited by 343
Alzheimer’s Disease: An Updated Overview of Its Genetics
Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336
Wang, C., Chen, S., Guo, H., Jiang, H., Liu, H., Fu, H., & Wang, D. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69714 · Cited by 327
Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent
Mehdi, S. F., Pusapati, S., Anwar, M. S., Lohana, D., Kumar, P., Nandula, S. A., Nawaz, F. K., Tracey, K., Yang, H., LeRoith, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148209 · Cited by 317
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
Pittock, R. R., Aakre, J. A., Castillo, A. M., Ramanan, V. K., Kremers, W. K., Jack, C. R., Vemuri, P., Lowe, V. J., Knopman, D. S., Petersen, R. C., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207770 · Cited by 151
Shi, L., Zhu, Q., Wang, Y., Hao, H., Zhang, H., Schwartz, J., Amini, H., van Donkelaar, A., Martin, R. V., Steenland, K., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211282119 · Cited by 145
Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions
Hou, Y., Chu, X., Park, J., Zhu, Q., Hussain, M., Li, Z., Madsen, H. B., Yang, B., Wei, Y., Wang, Y., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13847 · Cited by 145
Yaffe, K., Vittinghoff, E., Dublin, S., Peltz, C. B., Fleckenstein, L. E., Rosenberg, D. E., Barnes, D. E., Balderson, B. H., & Larson, E. B. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.6279 · Cited by 124
Chen, Y., He, Y., Han, J., Wei, W., & Chen, F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1258640 · Cited by 116
Li, Q., Yang, X., Xu, J., Guo, Y., He, X., Hu, H., Lyu, T., Marra, D., Miller, A., Smith, G., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12967 · Cited by 113
Dietary Patterns and Alzheimer’s Disease: An Updated Review Linking Nutrition to Neuroscience
Ellouze, I., Sheffler, J., Nagpal, R., & Arjmandi, B. (2023) · Nutrients · doi:10.3390/nu15143204 · Cited by 104
Fracassi, A., Marcatti, M., Tumurbaatar, B., Woltjer, R., Moreno, S., & Taglialatela, G. (2023) · Brain Pathology · doi:10.1111/bpa.13108 · Cited by 92
Dhana, K., Beck, T., Desai, P., Wilson, R. S., Evans, D. A., & Rajan, K. B. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13081 · Cited by 90
Tang, A. S., Rankin, K. P., Cerono, G., Miramontes, S., Mills, H., Roger, J., Zeng, B., Nelson, C., Soman, K., Woldemariam, S., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00573-8 · Cited by 86
Wang, L., Zhou, Y., Fang, X., & Qu, G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1004552 · Cited by 78
Mehta, R. I., Carpenter, J. S., Mehta, R. I., Haut, M. W., Wang, P., Ranjan, M., Najib, U., D’Haese, P.-F., & Rezai, A. R. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00447-y · Cited by 74
Lei, B., Li, Y., Fu, W., Yang, P., Chen, S., Wang, T., Xiao, X., Niu, T., Fu, Y., Wang, S., et al. (2024) · Medical Image Analysis · doi:10.1016/j.media.2024.103213 · Cited by 73
APOE4 confers transcriptomic and functional alterations to primary mouse microglia
Machlovi, S. I., Neuner, S. M., Hemmer, B. M., Khan, R., Liu, Y., Huang, M., Zhu, J. D., Castellano, J. M., Cai, D., Marcora, E., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105615 · Cited by 73
Shin, A., Koo, B. K., Lee, J. Y., & Kang, E. H. (2024) · BMJ · doi:10.1136/bmj-2024-079475 · Cited by 69
Pathophysiology of Alzheimer’s Disease
Yarns, B. C., Holiday, K. A., Carlson, D. M., Cosgrove, C. K., & Melrose, R. J. (2022) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2022.07.003 · Cited by 68
Puentes-Díaz, N., Chaparro, D., Morales-Morales, D., Flores-Gaspar, A., & Alí-Torres, J. (2023) · ACS Omega · doi:10.1021/acsomega.2c06939 · Cited by 67
Tau-targeting therapy in Alzheimer’s disease: Critical advances and future opportunities
Guo, Y., Li, S., Zeng, L.-H., & Tan, J. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.16 · Cited by 61
Dave, N., Judd, J. M., Decker, A., Winslow, W., Sarette, P., Villarreal Espinosa, O., Tallino, S., Bartholomew, S. K., Bilal, A., Sandler, J., et al. (2023) · Aging Cell · doi:10.1111/acel.13775 · Cited by 55
Sun, Y., Xu, L., Zheng, D., Wang, J., Liu, G., Mo, Z., Liu, C., Zhang, W., Yu, J., Xing, C., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102793 · Cited by 54
Tang, C., Wei, M., Sun, J., Wang, S., & Zhang, Y. (2023) · Journal of King Saud University - Computer and Information Sciences · doi:10.1016/j.jksuci.2023.101618 · Cited by 54
Early changes of fecal short‐chain fatty acid levels in patients with mild cognitive impairments
Gao, C., Li, B., He, Y., Huang, P., Du, J., He, G., Zhang, P., Tang, H., & Chen, S. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14252 · Cited by 50
Lee, C.-H., & Hung, S.-Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010031 · Cited by 50
Geng, M., Xie, X., Ye, Z., Wang, T., Li, G., Hu, S., Liu, X., & Meng, H. (2022) · IEEE/ACM Transactions on Audio Speech and Language Processing · doi:10.1109/taslp.2022.3195113 · Cited by 48
Mirkin, S., & Albensi, B. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1094233 · Cited by 46
Yaghmaei, E., Lu, H., Ehwerhemuepha, L., Zheng, J., Danioko, S., Rezaie, A., Sajjadi, S. A., & Rakovski, C. (2024) · Communications Medicine · doi:10.1038/s43856-024-00527-6 · Cited by 47
MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease
Li, W., & Zheng, Y. (2023) · Cells · doi:10.3390/cells12101378 · Cited by 43
The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.
Kostes, W. W., & Brafman, D. A. (2023) · Cells · doi:10.3390/cells12081204 · Cited by 43
Sala-Vila, A., Satizabal, C. L., Tintle, N., Melo van Lent, D., Vasan, R. S., Beiser, A. S., Seshadri, S., & Harris, W. S. (2022) · Nutrients · doi:10.3390/nu14122408 · Cited by 40
COVID-19 as a Risk Factor for Alzheimer’s Disease
Golzari-Sorkheh, M., Weaver, D. F., & Reed, M. A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220800 · Cited by 39
Wang, C., Tachimori, H., Yamaguchi, H., Sekiguchi, A., Li, Y., Yamashita, Y., & Initiative, F. A. D. N. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02819-w · Cited by 39
“As of 2022, there were an estimated 6.1 million patients with AD, and this number is estimated to grow to 13.8 million by 2060 in the USA alone [1].”
BackgroundInfluentialZhou, Y., Xu, J., Hou, Y., Bekris, L., Leverenz, J. B., Pieper, A. A., Cummings, J., & Cheng, F. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12350 · Cited by 39
Qiao, Y., Gu, J., Yu, M., Chi, Y., & Ma, Y. (2024) · CNS Drugs · doi:10.1007/s40263-024-01067-2 · Cited by 38
C/EBPβ/AEP Signaling Drives Alzheimer’s Disease Pathogenesis
Xiong, J., Zhang, Z., & Ye, K. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01025-w · Cited by 37
Han, A., Yuen, H. K., & Jenkins, J. (2023) · Journal of Health Psychology · doi:10.1177/13591053221141131 · Cited by 30
Park, S.-Y., Setiawan, V. W., Crimmins, E. M., White, L. R., Wu, A. H., Cheng, I., Darst, B. F., Haiman, C. A., Wilkens, L. R., Le Marchand, L., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000208116 · Cited by 33
Nemergut, M., Marques, S. M., Uhrik, L., Vanova, T., Nezvedova, M., Gadara, D. C., Jha, D., Tulis, J., Novakova, V., Planas-Iglesias, J., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00620-9 · Cited by 30
Liu, J., Liu, L., Zheng, L., Feng, K.-W., Wang, H.-T., Xu, J.-P., & Zhou, Z.-Z. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114503 · Cited by 28
Fitzgerald, G. S., Chuchta, T. G., & McNay, E. C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14160 · Cited by 22
Jensen, A. M. G., Raska, J., Fojtik, P., Monti, G., Lunding, M., Bartova, S., Pospisilova, V., van der Lee, S. J., Van Dongen, J., Bossaerts, L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408262121 · Cited by 22
Modulation of microRNAs through Lifestyle Changes in Alzheimer’s Disease
Pinto-Hernandez, P., Castilla-Silgado, J., Coto-Vilcapoma, A., Fernández-Sanjurjo, M., Fernández-García, B., Tomás-Zapico, C., & Iglesias-Gutiérrez, E. (2023) · Nutrients · doi:10.3390/nu15173688 · Cited by 22
Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
Xia, Z.-D., Ma, R.-X., Wen, J.-F., Zhai, Y.-F., Wang, Y.-Q., Wang, F.-Y., Liu, D., Zhao, X.-L., Sun, B., Jia, P., et al. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-230326 · Cited by 19
Sushma, Sahu, M. R., Murugan, N. A., & Mondal, A. C. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300245 · Cited by 17
Harrison, K. L., Garrett, S. B., Halim, M., Bernstein Sideman, A., Allison, T. A., Dohan, D., Naasan, G., Miller, B. L., Smith, A. K., & Ritchie, C. S. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220536 · Cited by 18
Johnston, J. L., Reda, S. M., Setti, S. E., Taylor, R. W., Berthiaume, A.-A., Walker, W. E., Wu, W., Moebius, H. J., & Church, K. J. (2023) · Neurotherapeutics · doi:10.1007/s13311-022-01325-5 · Cited by 18
Huggins, L. K. L., Min, S. H., Kaplan, S., Wei, J., Welsh-Bohmer, K., & Xu, H. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-221167 · Cited by 18
“Emerging research has shown racial and ethnic variations in the magnitude of association between the APOE (cid:2) 4 allele and ADRD risk [1–3].”
InfluentialWalsh, T., Duff, L., Riviere, M. E., Tariot, P. N., Doak, K., Smith, M., Borowsky, B., Lopez Lopez, C., Arratia, P. C., Liu, F., et al. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.27 · Cited by 18
Identifying progression-specific Alzheimer’s subtypes using multimodal transformer
Machado Reyes, D., Chao, H., Hahn, J., Shen, L., Yan, P., & Initiative, F. T. A. D. N. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14040421 · Cited by 17
Public spending on acute and long‐term care for Alzheimer's disease and related dementias
Coe, N. B., White, L., Oney, M., Basu, A., & Larson, E. B. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12657 · Cited by 17
Davidson, R., Krider, R. I., Borsellino, P., Noorda, K., Alhwayek, G., & Vida, T. A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110553 · Cited by 17
“The estimated prevalence of AD is estimated to increase to 13.8 million by 2060 [4].”
BackgroundInfluentialGuo, Q., Wang, T., Qian, C., & Wang, X. (2024) · Small · doi:10.1002/smll.202403980 · Cited by 15
Wang, T., Liu, X., Wang, X., Hua, F., & Yan, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1739875 · Cited by 14
Martos, D., Lőrinczi, B., Szatmári, I., Vécsei, L., & Tanaka, M. (2025) · doi:10.20944/preprints202504.1511.v2 · Cited by 13
Cortes-Flores, H., Torrandell-Haro, G., & Brinton, R. D. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1358568 · Cited by 12
Hirschman, K. B., McHugh, M., & Morgan, B. (2023) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12391 · Cited by 11
Song, M., & Fan, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098398 · Cited by 11
“Pathologically, brain cells and nerves are damaged by the aggregation of proteins, mitochondrial dysfunction, and inflammation of the brain, forming neural disconnection, neural death and synaptic dysfunction in the brain [1,2].”
BackgroundPapotti (2024) · doi:10.1177/13872877241284213 · Cited by 11
Radcliffe, K. G., Halim, M., Ritchie, C. S., Maus, M., & Harrison, K. L. (2023) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/10499091231155601 · Cited by 10
Önnestam, K., Nilsson, B., Rother, M., Rein-Hedin, E., Bylund, J., Anderer, P., Kemethofer, M., Halldin, M. M., Sandin, J., & Segerdahl, M. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.89 · Cited by 10
Estimating prevalence of early symptomatic Alzheimer's disease in the United States
Spargo, D., Zur, R., Lin, P., Synnott, P., Klein, E., & Hartry, A. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12497 · Cited by 9
“20 Therefore,ourbasecaseanalysisused an AD prevalence of 70% (with 60% and 80% used for uncertainty analyses).”
BackgroundHarrison, J. M., Sheng, F., Josberger, R. E., Liu, H. H., Stone, P. W., Luchsinger, J. A., & Dick, A. W. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.22520 · Cited by 7
Caregivers’ experience with Tele-Savvy Caregiver Program post-hospitalization
Kovaleva, M. A., Kleinpell, R., Dietrich, M. S., Jones, A. C., Boon, J. T., Duggan, M. C., Dennis, B. M., Lauderdale, J., & Maxwell, C. A. (2023) · Geriatric Nursing · doi:10.1016/j.gerinurse.2023.03.002 · Cited by 6
Wickline, J. L., Smith, S., Shin, R., Odfalk, K., Sanchez, J., Javors, M., Ginsburg, B., & Hopp, S. C. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109454 · Cited by 2
Metadata
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2022-03-14
- Volume
- 18
- Issue
- 4
- Pages
- 700-789
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W4220825176
- Cited by
- 2,341
- References
- 645
- FWCI
- 318.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.